Clinical strategies and therapies specifically designed to inhibit or reduce catabolism, the metabolic process involving the breakdown of complex molecules like muscle protein and bone matrix into simpler ones. The primary goal is to preserve lean body mass and structural integrity, which is critical for longevity and physical function. These interventions are often employed in contexts of aging, chronic stress, or caloric restriction.
Origin
The term combines the Greek prefix ‘anti-‘ meaning opposite, with ‘catabolism,’ derived from kata- (down) and ballein (to throw), signifying breakdown. Its clinical application arose from the study of metabolism, particularly in sports medicine and gerontology, where minimizing muscle wasting is a central therapeutic target. Understanding the balance between anabolism and catabolism is foundational to metabolic endocrinology.
Mechanism
These interventions function by modulating key hormonal and cellular pathways that drive tissue degradation. They may involve optimizing anabolic hormones such as testosterone and growth hormone, inhibiting glucocorticoids like cortisol, or supplying specific amino acid substrates to shift the net protein balance toward synthesis. The ultimate effect is a favorable shift in the anabolic-to-catabolic ratio, supporting tissue preservation.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.